Catalyst Pharma (DE:CN2)
FRANKFURT:CN2
Holding DE:CN2?
Track your performance easily

Catalyst Pharma (CN2) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Buy
16Bullish
0Neutral
6Bearish
Technical Analysis Consensus
Sell
4Bullish
0Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Catalyst Pharma’s (CN2) Moving Averages Convergence Divergence (MACD) indicator is 0.32, suggesting Catalyst Pharma is a Sell.
Catalyst Pharma’s (CN2) 20-Day exponential moving average is 18.23, while Catalyst Pharma’s (CN2) share price is €19.59, making it a Buy.
Catalyst Pharma’s (CN2) 50-Day exponential moving average is 17.62, while Catalyst Pharma’s (CN2) share price is €19.59, making it a Buy.

Catalyst Pharma (CN2) Pivot Points

Oct 19, 2024, 10:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.15
19.15
19.15
19.15
19.15
19.15
19.15
Fibonacci
19.15
19.15
19.15
19.15
19.15
19.15
19.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CN2) Moving Averages

Oct 19, 2024, 10:43 AM
Period
Simple
Exponential
MA5
18.71Buy
18.89Buy
MA10
18.29Buy
18.51Buy
MA20
18.13Buy
18.23Buy
MA50
17.93Buy
17.62Buy
MA100
16.28Buy
16.69Buy
MA200
15.09Buy
15.44Buy
Catalyst Pharma’s (CN2) 10-Day exponential moving average is 18.51, while Catalyst Pharma’s (CN2) share price is €19.59, making it a Buy.
Catalyst Pharma’s (CN2) 100-Day exponential moving average is 16.69, while Catalyst Pharma’s (CN2) share price is €19.59, making it a Buy.
Catalyst Pharma’s (CN2) stock price is €19.59 and Catalyst Pharma’s (CN2) 50-day simple moving average is 17.93, creating a Buy signal.
Catalyst Pharma’s (CN2) stock price is €19.59 and Catalyst Pharma’s (CN2) 100-day simple moving average is 16.28, creating a Buy signal.
Catalyst Pharma’s (CN2) stock price is €19.59 and Catalyst Pharma’s (CN2) 200-day simple moving average is 15.09, creating a Buy signal.

Catalyst Pharma (CN2) Technical Indicators

Oct 19, 2024, 10:43 AM
Name
Value
Implied Action
RSI (14)
72.32
Sell
STOCH (9,6)
99.06
Sell
STOCHRSI (14)
99.23
Sell
MACD (12,26)
0.32
Sell
ADX (14)
15.10
Buy
Williams %R
-2.31
Sell
CCI (14)
240.12
Sell
ATR (14)
0.27
-
Ultimate Oscillator
85.10
Buy
ROC
10.65
Buy
Catalyst Pharma’s (CN2) Relative Strength Index (RSI) is 72.32, creating a Sell signal.
Catalyst Pharma’s (CN2) Trend Strength Indicator (ADX) is 15.10, creating a Buy signal.
Catalyst Pharma’s (CN2) Commodity Channel Index (CCI) is 240.12, creating a Sell signal.
Catalyst Pharma’s (CN2) Price Rate of Change (ROC) is 10.65, creating a Buy signal.

FAQ

Is CN2 a Buy, Hold, or Sell?
Based on CN2’s technical indicators, CN2 is a Buy.
    What is CN2’s RSI (14)?
    CN2’s RSI (14) is 72.32, which suggests CN2 is a Sell.
      What is CN2’s MACD?
      CN2’s MACD is 0.32, which suggests CN2 is a Sell.
        What is CN2’s 5-day moving average?
        CN2’s 5-day moving average is 18.71, which suggests CN2 is a Buy.
          What is CN2’s 20-day moving average?
          CN2 20-day moving average is 18.13, which suggests CN2 is a Buy.
            What is CN2’s 50-day moving average?
            CN2’s 50-day moving average is 17.93, which suggests CN2 is a Buy.
              What is CN2’s 200-day moving average?
              CN2’s 200-day moving average is 15.09, which suggests CN2 is a Buy.
                What is CN2’s Williams % R (14)?
                CN2’s Williams % R (14) is -2.31, which suggests CN2 is a Sell.
                  What is CN2’s CCI (14)?
                  CN2’s CCI (14) is 240.12, which suggests CN2 is a Sell.
                    What is the share price of Catalyst Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis